- Set
- Facing a New Trial
- Number
- #013
- Market
- EU
- Rarity
- Fixed
- Variant
- Normal
Alolan Vulpix (sm2+ 013) Facing a New Trial JP Normal
Facing a New Trial / #013Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Source comparison — what each price means
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-10 | Sold | €5.38 | -1.6% |
| 2026-10-10 | List | €5.75 | -3.8% |
| 2026-09-13 | Sold | €5.47 | — |
| 2026-09-12 | Sold | €5.47 | — |
| 2026-09-12 | List | €5.98 | — |
| 2026-09-11 | Sold | €5.47 | — |
| 2026-09-10 | Sold | €5.47 | — |
| 2026-09-10 | List | €5.98 | — |
| 2026-09-09 | List | €5.98 | +0.2% |
| 2026-09-08 | Sold | €5.47 | — |
| 2026-09-08 | List | €5.97 | — |
| 2026-09-07 | List | €5.97 | — |
| 2026-09-06 | Sold | €5.47 | — |
| 2026-09-06 | List | €5.97 | +2.1% |
Alolan Vulpix (sm2+ 013) Facing a New Trial JP
Facing a New Trial / #013
Spain: lowest · Italy: below average · EU average €6.06Choose a region above to inspect its prices and history.
Market Data
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €5.38 | €2.49 | €5.99 | -1.6% | >5 | |
NMRAW | €5.38 | €2.49 | €5.99 | -1.6% | >5 |
Alolan Vulpix (sm2+ 013) Facing a New Trial JP Pokemon card price snapshot - Normal
Explore Alolan Vulpix (sm2+ 013) Facing a New Trial JP #013, Normal from Facing a New Trial, with 224 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.
- Market
- EU
- Set
- Facing a New Trial
- Variant
- Normal
- Rarity
- Fixed
- Activity
- 224 price records